Chin Hur, MD, MPH

Senior Scientist Hur, Chin
Assistant Professor of Medicine, Harvard Medical School
Director of GI Health Outcomes Research, MGH Gastrointestinal Unit
 
Mailing Address: Institute for Technology Assessment
Massachusetts General Hospital
101 Merrimac St., 10th FL
Boston, MA 02114

fax: 617-726-9414
Email address: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Description:

Dr. Hur received his bachelor degree from Columbia University, his MD and MPH degrees from Johns Hopkins University and completed his Internal Medicine residency at the Johns Hopkins Hospital. He subsequently completed his fellowship in Gastroenterology at the Beth Israel Deaconess Medical Center and then joined the faculty of the MGH Gastrointestinal Unit in 2002.

Dr. Hur's areas of clinical areas of interests include: gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal adenocarcinoma as well as gastrointestinal cancer screening. His research interest lies in outcomes research, specifically technology assessment with a focus on decision analysis and disease modeling, and the application of these methodologies to the management of cancers and pre-malignant states (e.g. dysplasia) in the gastrointestinal tract. This management includes the identification of clinical predictors, diagnostic algorithms, and the optimization of treatment.

Some of the specific projects that he has been involved with include a disease model of Barrett's Esophagus and Esophageal Cancer, an analysis of the impact of the implementation of Virtual Colonoscopies for colorectal cancer (CRC) screening and the possible role for chemoprevention in cancer care.

 

Publications

  • Hur, C., Miller, M., Kong, C. Y., Dowling, E., Nattinger, K., Dunn, M. & Feuer, E. J. (2013). Trends in esophageal adenocarcinoma incidence and mortality.. Cancer, 15(119(6)), 1149-58. [Online version]
  • Knudsen, A., Hur, C., Gazelle, G. S., Schrag, D., McFarland, E. G. & Kuntz, K. M. (2012). Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.. Ann Intern Med, 157(9), 611-620. [Online version]
  • Choi, S. E. & Hur, C. (2012). Screening and surveillance for Barrett's esophagus: current issues and future directions.. Curr Opin Gastroenterol, 28(4), 377-381. [Online version]
  • Ananthakrishnan, A. N., Hur, C. & Korzenik, J. R. (2012). Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci, 57, 472-80. [Online version]
  • Ananthakrishnan, A. N., Hur, C., Juillerat, P. & Korzenik, J. R. (2011). Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol, 106, 2009-17. [Online version]
 
[ Back ]
Banner